Dr. Melissa Ilardo

Yeah, I mean, it's a really great question. And I think one without a very good answer at this point. I think one of the things holding back this discussion up till now is that CRISPR is still a little bit of a blunt tool. You know, we're not, we haven't, like the way that we're applying it

Yeah, I mean, it's a really great question. And I think one without a very good answer at this point. I think one of the things holding back this discussion up till now is that CRISPR is still a little bit of a blunt tool. You know, we're not, we haven't, like the way that we're applying it

Yeah, I mean, it's a really great question. And I think one without a very good answer at this point. I think one of the things holding back this discussion up till now is that CRISPR is still a little bit of a blunt tool. You know, we're not, we haven't, like the way that we're applying it

Yeah, I mean, it's a really great question.

And I think one without a very good answer at this point.

I think one of the things holding back this discussion up till now is that CRISPR is still a little bit of a blunt tool.

You know, we're not, we haven't, like the way that we're applying it

isn't as precise as we'd like it to be to do the kind of gene editing that, you know, you would need to protect babies in the way that you're describing. And there are things like off-target effects, they say. So, you know, you're trying to edit one very specific part of the genome, but it ends up editing places that you didn't intend it to edit.

isn't as precise as we'd like it to be to do the kind of gene editing that, you know, you would need to protect babies in the way that you're describing. And there are things like off-target effects, they say. So, you know, you're trying to edit one very specific part of the genome, but it ends up editing places that you didn't intend it to edit.

isn't as precise as we'd like it to be to do the kind of gene editing that, you know, you would need to protect babies in the way that you're describing.

isn't as precise as we'd like it to be to do the kind of gene editing that, you know, you would need to protect babies in the way that you're describing. And there are things like off-target effects, they say. So, you know, you're trying to edit one very specific part of the genome, but it ends up editing places that you didn't intend it to edit.

And there are things like off-target effects, they say.

So, you know, you're trying to edit one very specific part of the genome, but

it ends up editing places that you didn't intend it to edit.

So that's kind of one of the issues, I think, technologically.

So that's kind of one of the issues, I think, technologically. I think if I remember right when that happened, people were a little bit like, that technology isn't ready to be used in that way yet. But, of course, that's something that is changing really rapidly. We're getting so much better at this. We're able to do it successfully in lab animals. And so, yeah, ethically, I mean, it's just –

So that's kind of one of the issues, I think, technologically. I think if I remember right when that happened, people were a little bit like, that technology isn't ready to be used in that way yet. But, of course, that's something that is changing really rapidly. We're getting so much better at this. We're able to do it successfully in lab animals. And so, yeah, ethically, I mean, it's just –

So that's kind of one of the issues, I think, technologically. I think if I remember right when that happened, people were a little bit like, that technology isn't ready to be used in that way yet. But, of course, that's something that is changing really rapidly. We're getting so much better at this. We're able to do it successfully in lab animals. And so, yeah, ethically, I mean, it's just –

I think if I remember right when that happened, people were a little bit like, that technology isn't ready to be used in that way yet.

But, of course, that's something that is changing really rapidly.